Roivant Sciences Ltd.(ROIV)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
ROIV | 24.86 B | -73.21x | -33.50% | - | $-0.47 | -8.52% | 2.18 | - | $37.97 | $11.94 |
CNTA | - | - | - | - | - | - | - | - | - | - |
GNS.L | 154.62 B | 3278.87x | -0.20% | 7.07% | $0.71 | 9.35% | 0.52 | 1.40% | $3228.38 | $1943.00 |
KNSA | 3.89 B | 81.28x | 55.40% | 9.59% | $0.99 | 14.04% | 1.36 | - | $82.94 | $33.45 |
CMPS | 1.84 B | -3.51x | - | - | $-3.79 | -3.19% | 0.65 | - | $15.40 | $4.40 |
Peer Valuation & Performance Analysis
Peer group analysis for Roivant Sciences Ltd. (ROIV) compared to its primary competitors (including CNTA, GNS.L, KNSA) reveals distinct metrics. ROIV trades at a valuation discount relative to its competitors, with a P/E ratio of -73.2x versus the peer average of 1118.9x (representing a 107% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, ROIV's revenue growth of -33.5% lags behind the peer average of 27.6%, indicating potential market share losses or slower industry adoption.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• ROIV ranks #0 in P/E ratio, #5 in revenue growth, and #3 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $34.35 | $34.43 | $33.67 | $34.41 | 6,859,200 | +0.17% |
| 2026-09-02 | $34.64 | $35.04 | $33.43 | $34.18 | 6,196,100 | -1.33% |
| 2026-09-01 | $34.64 | $34.95 | $34.26 | $34.52 | 6,905,900 | -0.35% |
| 2026-08-31 | $34.83 | $35.34 | $34.02 | $34.64 | 39,466,600 | -0.55% |
| 2026-08-28 | $37.01 | $37.13 | $34.69 | $34.71 | 8,765,000 | -6.21% |
| 2026-08-27 | $36.84 | $37.81 | $36.50 | $37.58 | 4,920,800 | +1.99% |
| 2026-08-26 | $36.92 | $36.93 | $36.32 | $36.75 | 5,260,300 | -0.47% |
| 2026-08-25 | $36.82 | $37.29 | $36.31 | $36.47 | 4,481,400 | -0.95% |
| 2026-08-24 | $36.22 | $36.57 | $35.70 | $36.36 | 5,117,100 | +0.39% |
| 2026-08-21 | $37.03 | $37.18 | $36.23 | $36.30 | 6,185,500 | -1.97% |
| 2026-08-20 | $36.91 | $37.55 | $36.68 | $36.84 | 3,127,800 | -0.19% |
| 2026-08-19 | $37.83 | $37.97 | $36.75 | $37.40 | 5,814,700 | -1.14% |
| 2026-08-18 | $35.91 | $37.46 | $35.86 | $37.37 | 6,409,500 | +4.07% |
| 2026-08-17 | $36.22 | $37.19 | $35.65 | $36.24 | 7,729,900 | +0.06% |
| 2026-08-14 | $36.13 | $36.49 | $35.87 | $36.20 | 4,527,200 | +0.18% |
Explore More Analysis for ROIV
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.